Related Experiment Video
Updated: Jun 28, 2026

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
[Mitochondrial mechanisms of apoptosis in response to DNA damage]
Abstract:
Integrity of genome is a prerequisite for cell viability. Therefore, targeted damage of DNA structure is considered the key approach to the induction of cell death. Among the plethora of death execution programs the mitochondrial events are of the utmost importance. However, the epigemetic activation of defense mechanisms in response to DNA damage limit cell death. This review analyses the outcome of the genotoxic stress (i.e., cell death versus survival) as a balance of pro- and anti-apoptotic signaling. Practically speaking, the combinations of DNA damaging agents with the inhibitors of anti-apoptosis would increase the efficacy of anticancer therapy.
Insights
Targeting DNA structure induces cell death, crucial for cancer therapy. Inhibiting anti-apoptotic defenses alongside DNA damage boosts treatment effectiveness by tipping the balance toward cell death.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Context:
- Genomic integrity is essential for cell survival.
- Targeted DNA damage is a primary strategy for inducing cell death.
- Mitochondrial pathways are critical in executing cell death programs.
Purpose:
- To review the balance between pro-apoptotic and anti-apoptotic signaling in response to genotoxic stress.
- To analyze the factors influencing cell death versus cell survival after DNA damage.
- To explore strategies for enhancing anticancer therapy efficacy.
Summary:
- Genotoxic stress, or DNA damage, triggers cell death pathways, with mitochondrial events being particularly important.
- Epigenetic activation of cellular defense mechanisms can counteract DNA damage-induced cell death, promoting survival.
- The outcome of genotoxic stress depends on the intricate balance between pro-apoptotic and anti-apoptotic signaling.
Impact:
- Understanding this balance is key to developing effective cancer treatments.
- Combining DNA-damaging agents with inhibitors of anti-apoptotic proteins can significantly enhance therapeutic outcomes.
- This approach holds promise for overcoming treatment resistance and improving patient survival rates in oncology.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Apoptosis
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Overview of DNA Repair
Chemically...
Overview of DNA Repair
Chemically...

